_ok_o_ff.png)
1.png)
Polymer–Drug Conjugates for Oral Delivery: Design Strategies, Barriers, and Translational Progress
Abstract
Keywords
Full Text:
PDFReferences
J. Ouyang et al., “Oral drug delivery platforms for biomedical applications,” Materials Today. [Online]. Available: https://doi.org/10.1016/j.mattod.2023.01.002
M. Irwin and L. A. Johnson, “Factors infuencing oral adherence: Qualitative metasummary and triangulation with quantitative evidence,” Clinical Journal of Oncology Nursing. [Online]. Available: https://doi.org/10.1188/15.S1.CJON.6-30
S. Hua, “Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract - Influence of Physiological, Pathophysiological and Pharmaceutical Factors,” Frontiers in Pharmacology. [Online]. Available: https://doi.org/10.3389/fphar.2020.00524
P. Viswanathan, Y. Muralidaran, and G. Ragavan, “Challenges in oral drug delivery: a nano-based strategy to overcome,” Nanostructures for Oral Medicine. [Online]. Available: https://doi.org/10.1016/B978-0-323-47720-8.00008-0
M. Azman, A. H. Sabri, Q. K. Anjani, M. F. Mustaffa, and K. A. Hamid, “Intestinal Absorption Study: Challenges and Absorption Enhancement Strategies in Improving Oral Drug Delivery,” Pharmaceuticals. [Online]. Available: https://doi.org/10.3390/ph15080975
H. Ringsdorf, “Structure and Properties of Pharmacologycally Active Polymers,” Polymer Symposia. [Online]. Available: https://doi.org/10.1002/polc.5070510111
P. A. Vasey et al., “Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates,” Clinical Cancer Research. [Online]. Available: https://aacrjournals.org/clincancerres/article/5/1/83/287445/Phase-I-Clinical-and-Pharmacokinetic-Study-of-PK1
I. F. Uchegbu, A. G. Schätzlein, W. P. Cheng, and A. Lalatsa, Fundamentals of Pharmaceutical Nanoscience, 2nd ed. London: Springer Science+Business Media, 2024. [Online]. Available: http://ndl.ethernet.edu.et/bitstream/123456789/10995/1/1143.pdf
J. Madan, A. Baldi, M. Chaudhary, and N. Chopra, Polymer-drug conjugates : linker chemistry, protocols and applications. London: Academic Press, 2023. [Online]. Available: https://www.sciencedirect.com/science/book/9780323916639
C. Fante, M. J. Vicent, and F. Greco, “Polymer-drug conjugates,” in Fundamentals of Pharmaceutical Nanoscience, 2024, pp. 109–137. [Online]. Available: https://doi.org/10.1007/978-3-031-59478-6_6
FDA, “Approval letter Movantik,” Food and Drug Administration. Accessed: Nov. 20, 2025. [Online]. Available: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/204760Orig1s000Approv.pdf
FDA, “Approval Letter Adagen,” Food and Drug Administration. Accessed: Nov. 23, 2025. [Online]. Available: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process
FDA, “Approval Letter Neulasta,” Food and Drug Administration. Accessed: Nov. 23, 2025. [Online]. Available: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/125031_000_Neulasta_Approv.pdf
P. A. Dinndorf, J. Gootenberg, M. H. Cohen, P. Keegan, and R. Pazdur, “FDA Drug Approval Summary: Pegaspargase (Oncaspar®) for the First-Line Treatment of Children with Acute Lymphoblastic Leukemia,” Oncologist, vol. 12, no. 8, pp. 991–998, Aug. 2007. [Online]. Available: https://doi.org/10.1634/theoncologist.12-8-991
FDA, “Approval Letter Plegridy,” Food and Drug Administration. Accessed: Nov. 23, 2025. [Online]. Available: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/125499Orig1s000Approv.pdf
FDA, “Approval Letter Adynovate,” Food and Drug Administration. Accessed: Nov. 23, 2025. [Online]. Available: https://wayback.archive-it.org/7993/20190425001537/https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/UCM472754.pdf
FDA, “Approval letter Revcovi,” Food and Drug Administration. Accessed: Nov. 20, 2025. [Online]. Available: https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/761092Orig1s000ltr.pdf
FDA, “Approval letter Enhertu,” Food and Drug Administration. Accessed: Nov. 20, 2025. [Online]. Available: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/761139Orig1s000Approv.pdf
FDA, “A Phase 3 Randomized Open Label Study to Compare NKTR-214 Combined with Nivolumab to the Investigator’s Choice of Sunitinib or Cabozantinib in Patients with Previously Untreated Advanced Renal Cell Carcinoma,” Food and Drug Administration. Accessed: Nov. 23, 2025. [Online]. Available: https://cdn.clinicaltrials.gov/large-docs/45/NCT03729245/Prot_000.pdf
I. H. Park et al., “An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer,” Cancer Research and Treatment. [Online]. Available: https://doi.org/10.4143/crt.2016.289
FDA, “Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID),” Food and Drug Administration. Accessed: Nov. 23, 2025. [Online]. Available: https://clinicaltrials.gov/study/NCT05024773
L. C. Scott et al., “A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma,” Cancer Chemotherapy and Pharmacology. [Online]. Available: https://doi.org/10.1007/s00280-008-0746-2
D. P. Nowotnik, “AP5346 (ProLindacTM), A DACH Platinum Polymer Conjugate in Phase II Trials Against Ovarian Cancer,” Current Bioactive Compounds. [Online]. Available: https://doi.org/10.2174/157340711795163794
FDA, “Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer,” Food and Drug Administration. Accessed: Nov. 23, 2025. [Online]. Available: https://clinicaltrials.gov/study/NCT00291785
N. Avramović, B. Mandić, A. Savić-Radojević, and T. Simić, “Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy,” Pharmaceutics. [Online]. Available: https://doi.org/10.3390/pharmaceutics12040298
FDA, “NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer,” National Library of Medicine. Accessed: Nov. 20, 2025. [Online]. Available: https://www.clinicaltrials.gov/study/NCT00856375
A. Imantay, N. Mashurov, B. A. Zhaisanbayeva, and E. A. Mun, “Doxorubicin-Conjugated Nanoparticles for Potential Use as Drug Delivery Systems,” Nanomaterials. [Online]. Available: https://doi.org/10.3390/nano15020133
FDA, “Polyethylene Glycol Loxenatide Pharmacokinetics Study in Subjects With Normal and Insufficiency Renal Function,” National Library of Medicine. Accessed: Nov. 20, 2025. [Online]. Available: https://www.clinicaltrials.gov/study/NCT02467790#study-overview
S. Merali et al., “First-in-human study to assess the safety, pharmacokinetics, and pharmacodynamics of BMS-986141, a novel, reversible, small-molecule, PAR4 agonist in non-Japanese and Japanese healthy participants,” Platelets. [Online]. Available: https://doi.org/10.1080/09537104.2023.2222846
L. Yang et al., “Preclinical and first-in-human of purinostat mesylate, a novel selective HDAC I/IIb inhibitor, in relapsed/refractory multiple myeloma and lymphoma,” Signal Transduction and Targeted Therapy. [Online]. Available: https://doi.org/10.1038/s41392-025-02285-w
A. Javia et al., “Polymer-drug conjugates: Design principles, emerging synthetic strategies and clinical overview,” International Journal of Pharmaceutics. [Online]. Available: https://doi.org/10.1016/j.ijpharm.2022.121863
Y. Shen, Functional Polymers for Nanomedicine. RSC Publishing, 2013. [Online]. Available: https://doi.org/10.1039/9781849737388-00302
Y. Vo et al., “Solvent Choice during Flow Assembly of Photocross-Linked Single-Chain Nanoparticles and Micelles Affects Cellular Uptake,” Applied Materials and Interfaces. [Online]. Available: https://doi.org/10.1021/acsami.4c12186
T. Sakai, T. Ishihara, and M. Higaki, “Stealth-type polymeric nanoparticles with encapsulated betamethasone phosphate for treatment of intraocular inflammation,” Ocular Drug Delivery Systems: Barriers and Application of Nanoparticulate Systems. [Online]. Available: https://doi.org/10.1201/b12950
E. V. B. van Gaal and D. J. A. Crommelin, “Polymeric micelles,” Advances in the Pharmaceutical Sciences Series. [Online]. Available: https://doi.org/10.1007/978-3-319-16241-6_2
E. R. Gillies, “pH-Sensitive Polymer-Drug Conjugates,” Chemistry of Materials. [Online]. Available: https://doi.org/10.1021/acs.chemmater.4c01700
G. Leriche, L. Chisholm, and A. Wagner, “Cleavable linkers in chemical biology,” Bioorganic and Medicinal Chemistry. [Online]. Available: https://doi.org/10.1016/j.bmc.2011.07.048
P. H. Toy and Yulin. Lam, Solid-phase organic synthesis : concepts, strategies, and applications. Wiley, 2012. [Online]. Available: https://api.pageplace.de/preview/DT0400.9781118141625_A23900670/preview-9781118141625_A23900670.pdf
P. V. Ravikanth and K. V. Ramanamurthy, “Potential of dendrimers as oral drug delivery carriers,” Journal of Applied Pharmaceutical Science. [Online]. Available: https://doi.org/10.7324/JAPS.2018.8723
H. Lennernäs, “Intestinal permeability and its relevance for absorption and elimination,” Xenobiotica. [Online]. Available: https://doi.org/10.1080/00498250701704819
S. Berg et al., “Intestinal Absorption of FITC-Dextrans and Macromolecular Model Drugs in the Rat Intestinal Instillation Model,” Molecular Pharmaceutics. [Online]. Available: https://doi.org/10.1021/acs.molpharmaceut.2c00261
J. W. Park, S. K. Kim, T. A. Al-Hilal, O. C. Jeon, H. T. Moon, and Y. Byun, “Strategies for oral delivery of macromolecule drugs,” Biotechnology and Bioprocess Engineering. [Online]. Available: https://doi.org/10.1007/s12257-009-3058-4
J. Liu, N. Ma, D. Zhao, Z. Li, and Y. Luan, “Spiral assembly of amphiphilic cytarabine prodrug assisted by probe sonication: Enhanced therapy index for leukemia,” Colloids and Surfaces B: Biointerfaces. [Online]. Available: https://doi.org/10.1016/j.colsurfb.2015.10.034
M. Anwar et al., “Enhanced bioavailability of nano-sized chitosan-atorvastatin conjugate after oral administration to rats,” European Journal of Pharmaceutical Sciences. [Online]. Available: https://doi.org/10.1016/j.ejps.2011.08.001
K. Fuhrmann and G. Fuhrmann, “Recent advances in oral delivery of macromolecular drugs and benefits of polymer conjugation,” Current Opinion in Colloid & Interface Science. [Online]. Available: https://doi.org/10.1016/J.COCIS.2017.07.002
M. U. Ghori and B. R. Conway, “Hydrophilic Matrices for Oral Control Drug Delivery,” American Journal of Pharmacological Sciences. [Online]. Available: http://eprints.hud.ac.uk/id/eprint/25980/http://eprints.hud.ac.uk/
R. Sharma et al., “Recent Advances in Polymer Drug Conjugates,” Mini-Reviews in Medicinal Chemistry. [Online]. Available: https://doi.org/10.2174/1389557515666150519104507
S. Aryal, C. M. J. Hu, V. Fu, and L. Zhang, “Nanoparticle drug delivery enhances the cytotoxicity of hydrophobic–hydrophilic drug conjugates,” Journal of Materials Chemistry. [Online]. Available: http://doi.org/10.1039/C1JM13834K
L. Shi et al., “Docetaxel-conjugated monomethoxy-poly(ethylene glycol)-b-poly(lactide) (mPEG-PLA) polymeric micelles to enhance the therapeutic efficacy in oral squamous cell carcinoma,” RSC Advances. [Online]. Available: http://doi.org/10.1039/C6RA03332F
H. Guo and P. Mi, “Polymer–drug and polymer–protein conjugated nanocarriers: Design, drug delivery, imaging, therapy, and clinical applications,” WIREs Nanomedicine and Nanobiotechnology. [Online]. Available: https://doi.org/10.1002/wnan.1988
A. Dadwal, A. Garg, B. Kumar, R. K. Narang, and N. Mishra, “Polymer-drug conjugates: Origins, progress to date, and future directions,” Smart Polymeric Nano-Constructs in Drug Delivery: Concept, Design and Therapeutic Applications. [Online]. Available: http://doi.org/10.1016/B978-0-323-91248-8.00015-5
X. Lu, H. Wu, Y. Liang, Z. Zhang, and H. X. Lv, “Redox-responsive prodrug for improving oral bioavailability of paclitaxel through bile acid transporter-mediated pathway,” International Journal of Pharmaceutics. [Online]. Available: http://doi.org/10.1016/j.ijpharm.2021.120496
P. R. Sarika, N. R. James, P. R. A. Kumar, D. K. Raj, and T. V. Kumary, “Gum arabic-curcumin conjugate micelles with enhanced loading for curcumin delivery to hepatocarcinoma cells,” Carbohydrate Polymers. [Online]. Available: http://doi.org/10.1016/j.carbpol.2015.07.068
Q. Tian et al., “Celastrol-conjugated carboxylmethyl chitosan for oral treatment of diet-induced obesity,” Journal of Drug Delivery Science and Technology. [Online]. Available: http://doi.org/10.1016/j.jddst.2021.102408
X. Zeng et al., “Celastrol-conjugated chitosan oligosaccharide for the treatment of pancreatic cancer,” Drug Delivery. [Online]. Available: http://doi.org/10.1080/10717544.2021.2018521
A. L. A. Cesar et al., “New mesalamine polymeric conjugate for controlled release: Preparation, characterization and biodistribution study,” European Journal of Pharmaceutical Sciences. [Online]. Available: http://doi.org/10.1016/j.ejps.2017.09.037
L. Kaur, R. Raj, A. K. Thakur, and I. Singh, “Development of chitosan-catechol conjugates as mucoadhesive polymer: Assessment of acute oral toxicity in mice,” Environmental Analysis Health and Toxicology. [Online]. Available: http://doi.org/10.5620/eaht.2020014
R. Miao et al., “Oral delivery of decanoic acid conjugated plant protein shell incorporating hybrid nanosystem leverage intestinal absorption of polyphenols,” Biomaterials. [Online]. Available: http://doi.org/10.1016/j.biomaterials.2022.121373
J. Varshosaz et al., “Synthesis and evaluation of dextran-budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis,” International Journal of Pharmaceutics. [Online]. Available: http://doi.org/10.1016/j.ijpharm.2008.08.034
S. A. Jacques et al., “From solution to in-cell study of the chemical reactivity of acid sensitive functional groups: a rational approach towards improved cleavable linkers for biospecific endosomal release,” Organic & Biomolecular Chemistry. [Online]. Available: http://doi.org/10.1039/C6OB00846A
B. D. Nkazi, E. W. Neuse, E. R. Sadiku, and B. A. Aderibigbe, “Synthesis, characterization, kinetic release study and evaluation of hydrazone linker in ferrocene conjugates at different pH values,” Journal of Drug Delivery Science and Technology. [Online]. Available: https://doi.org/10.1016/S1773-2247(13)50082-7
S. Kumar, B. Sharma, T. R. Bhardwaj, and R. K. Singh, “Design, synthesis and studies on novel polymeric prodrugs of erlotinib for colon drug delivery,” Anti-Cancer Agents in Medicinal Chemistry. [Online]. Available: https://doi.org/10.2174/1871520620666200811124013
Y. Lee et al., “Celecoxib coupled to dextran via a glutamic acid linker yields a polymeric prodrug suitable for colonic delivery,” Drug Design, Development and Therapy. [Online]. Available: https://doi.org/10.2147/DDDT.S89077
A. H. El-Kamel, A. A. M. Abdel-Aziz, A. J. Fatani, and H. I. El-Subbagh, “Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: Synthesis, in vitro and in vivo assessment,” International Journal of Pharmaceutics. [Online]. Available: https://doi.org/10.1016/j.ijpharm.2008.04.021
M. Hong et al., “A glutathione-responsive L-carnitine-modified camptothecin oral nano-prodrug for cancer therapy,” Journal of Molecular Structure. [Online]. Available: https://doi.org/10.1016/j.molstruc.2025.142744
W. Ren et al., “Folate-targeting and reduction-responsive nano-delivery system based on curcumin polymer to enhance the anti-cancer activity,” Journal of Drug Delivery Science and Technology. 2025. [Online]. Available: https://doi.org/10.1016/j.jddst.2025.106616
He et al., “A dextran–platinum(iv) conjugate as a reduction-responsive carrier for triggered drug release,” Journal of Materials Chemistry B. 2015. [Online]. Available: http://doi.org/10.1039/C5TB01496D
A. K. Mohanty, F. Dilnawaz, G. P. Mohanta, and S. K. Sahoo, “Polymer–Drug Conjugates for Targeted Drug Delivery,” in Targeted Drug Delivery : Concepts and Design, P. V Devarajan and S. Jain, Eds., Cham: Springer International Publishing, 2015, pp. 389–407. [Online]. Available: https://doi.org/10.1007/978-3-319-11355-5_12
R. He and C. Yin, “Trimethyl chitosan based conjugates for oral and intravenous delivery of paclitaxel,” Acta Biomaterialia. [Online]. Available: https://doi.org/10.1016/j.actbio.2017.02.012
J. Chi et al., “Studies on anti-hepatocarcinoma effect, pharmacokinetics and tissue distribution of carboxymethyl chitosan based norcantharidin conjugates,” Carbohydrate Polymers. [Online]. Available: https://doi.org/10.1016/j.carbpol.2019.115297
Y. Hou, J. Yao, J. Hu, and D. Xia, “Inflammation-retentive hyaluronic acid-mesalamine conjugate for enhanced oral therapy in ulcerative colitis,” International Journal of Biological Macromolecules. [Online]. Available: http://doi.org/10.1016/j.ijbiomac.2025.144949
A. Sood, A. Gupta, R. Bharadwaj, P. Ranganath, N. Silverman, and G. Agrawal, “Biodegradable disulfide crosslinked chitosan/stearic acid nanoparticles for dual drug delivery for colorectal cancer,” Carbohydrate Polymers. [Online]. Available: http://doi.org/10.1016/j.carbpol.2022.119833
S. Ma et al., “Orally available dextran-aspirin nanomedicine modulates gut inflammation and microbiota homeostasis for primary colorectal cancer therapy,” Journal of Controlled Release. [Online]. Available: http://doi.org/10.1016/j.jconrel.2024.05.002
T. Naki, W. M. R. Matshe, M. O. Balogun, S. Sinha Ray, S. A. Egieyeh, and B. A. Aderibigbe, “Polymer drug conjugates containing memantine, tacrine and cinnamic acid: promising nanotherapeutics for the treatment of Alzheimer’s disease,” Journal of Microencapsulation. [Online]. Available: http://doi.org/10.1080/02652048.2023.2167011
Z. Li et al., “Critical determinant of intestinal permeability and oral bioavailability of pegylated all trans-retinoic acid prodrug-based nanomicelles: Chain length of poly (ethylene glycol) corona,” Colloids Surf. B Biointerfaces, vol. 130, pp. 133–140, Jun. 2015. [Online]. Available: https://doi.org/10.1016/j.colsurfb.2015.03.036
N. Mozafari, F. Farjadian, M. S. Samani, S. Azadi, and A. Azadi, “Simvastatin-chitosan-citicoline conjugates nanoparticles as the co-delivery system in Alzheimer susceptible patients,” International Journal of Biological Macromolecules. [Online]. Available: https://doi.org/10.1016/j.ijbiomac.2019.11.180
X. Zhang, F. Han, Q. Yang, X. Zhao, and J. Jiang, “Quercetin conjugated xylan nanomicelles with P-gp inhibition and enhancement of oral bioavailability of insoluble drug Coenzyme Q10,” European Polymer Journal. [Online]. Available: https://doi.org/10.1016/J.EURPOLYMJ.2025.114299
I. Ekladious, Y. L. Colson, and M. W. Grinstaff, “Polymer–drug conjugate therapeutics: advances, insights and prospects,” Nature Reviews Drug Discovery. [Online]. Available: https://doi.org/10.1038/s41573-018-0005-0
P. Thakor, V. Bhavana, R. Sharma, S. Srivastava, S. B. Singh, and N. K. Mehra, “Polymer–drug conjugates: recent advances and future perspectives,” Drug Discovery Today. [Online]. Available: https://doi.org/10.1016/j.drudis.2020.06.028
J. Renukuntla, A. D. Vadlapudi, A. Patel, S. H. S. Boddu, and A. K. Mitra, “Approaches for enhancing oral bioavailability of peptides and proteins,” International Journal of Pharmaceutics. [Online]. Available: https://doi.org/10.1016/j.ijpharm.2013.02.030
P. Lundquist and P. Artursson, “Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues,” Advanced Drug Delivery Reviews. [Online]. Available: https://doi.org/10.1016/j.addr.2016.07.007
DOI: https://doi.org/10.37311/jsscr.v8i2.37187
Refbacks
- There are currently no refbacks.
Copyright (c) 2026 Journal Syifa Sciences and Clinical Research
| EDITORIAL OFFICE OF JOURNAL SYIFA SCIENCES AND CLINICAL RESEARCH |
| Department of Pharmacy, Gorontalo State University Jl. Jenderal Sudirman No.6, Kota Gorontalo, Provinsi Gorontalo 96128, Indonesia |
| Email: [email protected] Google Scholar : JOURNAL SYIFA SCIENCES AND CLINICAL RESEARCH |
